These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20606697)

  • 1. A newly identified derivative of amphotericin B: isolation, structure determination and primary evaluation of the activity and toxicity.
    Wang YH; Zhang JP; Chang Y; Hu CQ
    J Antibiot (Tokyo); 2010 Sep; 63(9):553-7. PubMed ID: 20606697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, structure elucidation and activity of an unknown impurity of amphotericin B.
    Li J; Zhu HQ; Li JY; Jin SH; Hu CQ
    J Antibiot (Tokyo); 2007 Apr; 60(4):272-6. PubMed ID: 17456979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.
    Paquet V; Volmer AA; Carreira EM
    Chemistry; 2008; 14(8):2465-81. PubMed ID: 18196508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of purity and potency of amphotericin B by HPLC.
    Chang Y; Wang YH; Hu CQ
    J Antibiot (Tokyo); 2011 Nov; 64(11):735-9. PubMed ID: 21971300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologically active amphotericin B-calix[4]arene conjugates.
    Paquet V; Zumbuehl A; Carreira EM
    Bioconjug Chem; 2006; 17(6):1460-3. PubMed ID: 17105224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Szlinder-Richert J; Cybulska B; Grzybowska J; Borowski E; Prasad R
    Acta Biochim Pol; 2000; 47(1):133-40. PubMed ID: 10961686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(1-piperidinepropionyl)amphotericin B methyl ester (PAME)--a new derivative of the antifungal antibiotic amphotericin B: searching for the mechanism of its reduced toxicity.
    Hac-Wydro K; Dynarowicz-Latka P; Grzybowska J; Borowski E
    J Colloid Interface Sci; 2005 Jul; 287(2):476-84. PubMed ID: 15925613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive fluorinated derivative of amphotericin B.
    Matsumori N; Umegawa Y; Oishi T; Murata M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3565-7. PubMed ID: 15963721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targeting system for antimycotic drugs: beta-glucosidase sensitive amphotericin B-star poly(ethylene glycol) conjugate.
    Sedlák M; Drabina P; Bílková E; Simůnek P; Buchta V
    Bioorg Med Chem Lett; 2008 May; 18(9):2952-6. PubMed ID: 18396401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physico-chemical and microbiological comparison of nystatin, amphotericin A and amphotericin B, and structure of amphotericin A.
    Aszalos A; Bax A; Burlinson N; Roller P; McNeal C
    J Antibiot (Tokyo); 1985 Dec; 38(12):1699-713. PubMed ID: 3912360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane interaction of amphotericin B as single-length assembly examined by solid state NMR for uniformly 13C-enriched agent.
    Matsuoka S; Ikeuchi H; Umegawa Y; Matsumori N; Murata M
    Bioorg Med Chem; 2006 Oct; 14(19):6608-14. PubMed ID: 16782343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B.
    Zumbuehl A; Stano P; Sohrmann M; Peter M; Walde P; Carreira EM
    Org Biomol Chem; 2007 May; 5(9):1339-42. PubMed ID: 17464400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
    Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Photostability of antifungal agents. 2. Photostability of polyene antibiotics].
    Thoma K; Kübler N
    Pharmazie; 1997 Apr; 52(4):294-302. PubMed ID: 9190607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate.
    Groeschke J; Solassol I; Bressolle F; Pinguet F
    J Pharm Biomed Anal; 2006 Sep; 42(3):362-6. PubMed ID: 16740372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of amphotericin B derivatives.
    Volmer AA; Szpilman AM; Carreira EM
    Nat Prod Rep; 2010 Sep; 27(9):1329-49. PubMed ID: 20556271
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.